MORGAN STANLEY

Position in SABS — SAB Biotherapeutics, Inc.

CIK 895421 NEW YORK, NY

Position in SABS

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$45,618

+$29,679 QoQ

Shares Held

11,911

+179.5% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#60

of 76 holders

Holding Since

Mar 2024

9 quarters on record

Voting authority Sole 98.58953908152128.ToString("F0")% Shared 0.ToString("F0")% None 1.4104609184787171.ToString("F0")%

Healthcare · as of Mar 31, 2026

MORGAN STANLEY holds $15,438,935,225 across 518 Biotechnology names. SABS ranks #380 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc	43,571,633	$2,090,131,227
2	ROIV	Roivant Sciences Ltd.	51,828,325	$1,435,644,595
3	VRTX	Vertex Pharmaceuticals Inc / Ma	3,188,881	$1,423,962,911
4	REGN	Regeneron Pharmaceuticals, Inc.	1,319,329	$1,019,366,352
5	TECH	BIO-TECHNE Corp	8,532,873	$445,927,935
6	MRNA	Moderna, Inc.	8,471,263	$430,340,154
7	ARGX	Argenx SE	560,711	$409,459,203
8	APLS	Apellis Pharmaceuticals, Inc.	10,042,399	$404,005,708

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$45,618	11,911	+179.5%	Shares	Defined	2026-05-15
2025-12-31	$15,939	4,262	+2436.9%	Shares	Defined	2026-05-27
2025-09-30	$337	168	0.0%	Shares	Defined	2026-05-27
2025-06-30	$294	168	-62.6%	Shares	Defined	2025-08-15
2025-03-31	$610	449	-25.0%	Shares	Defined	2025-05-15
2024-12-31	$2,272	599	-14.3%	Shares	Defined	2025-05-15
2024-09-30	$1,886	699	0.0%	Shares	Defined	2025-05-14
2024-06-30	$2,166	699	-41.7%	Shares	Defined	2025-05-14
2024-03-31	$5,442	1,199	—	Shares	Defined	2024-10-17
No filing history on record for this holder in this stock.